FDA Approved: SULINDAC — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for the generic NSAID sulindac from PuraCap Laboratories LLC dba Blu Pharmaceuticals (ANDA072711).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Sulindac (sulindac)

Snippet

SUPPL AP for SULINDAC (SULINDAC)